Concepedia

Lori J. Wirth

LJ

Statistics

Publications

173

Citations

18.8K

H-Index

64

Active since

1993

Affiliations

Massachusetts General Hospital(Current)

Harvard University

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Lori J. Wirth is an author at Massachusetts General Hospital specializing in medicine, oncology, and thyroid cancer.

Publications per year

1993–2025

173

Publications

173

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Martin Schlumberger, Makoto Tahara, Lori J. Wirth et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Cabozantinib in Progressive Medullary Thyroid Cancer

Rossella Elisei, Martin Schlumberger, Stefan Müller et al. · Journal of Clinical Oncology · 2013 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +14

Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers

Lori J. Wirth, Eric J. Sherman, Bruce Robinson et al. · New England Journal of Medicine · 2020 · 773 citations · Full text

Medicine, Endocrinology, Oncology +16

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister et al. · Journal of Clinical Oncology · 2017 · 652 citations

Medicine, Oncology, Pharmacology +17

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Harold J. Burstein, Lada Krilov, Jeanny B. Aragon‐Ching et al. · Journal of Clinical Oncology · 2017 · 601 citations

Medicine, Cancer Biology, Oncology +7

1–5 of 173